I have to say I agree with Narmac here. To me buying cheap shares with no idea how the path forward looks is just throwing good money after bad. Sure the science does still seem to be amazing, and even getting better looking as the potential financial market for NAFLD dwarfs the potential of all the other applications for Apabetalone. However until the company gets an executive and governance that can come up with and execute on a real business plan to deliver on the promise of the science I don't see anything moving this stock price.

McCaffrey said that he thought the market environment would "improve in the fall" but that kind of share price improvement is usually reserved for companies that have something positive to show the market. I doubt if there are many investors left who are going to give this management/governance group any credit for anything said on a forward looking basis. I don't think I have ever seen a management/governance group that was so consistently wrong for so long and yet still kept their jobs.  So much opportunity squandered, 3 years since BoM failed to reach its end points, 2+ years since McCaffrey said covid trials would be initiated quickly, into our 3rd year with BTD and yet no meaningful activity, on and on...

It would seem at this point with all the potential in the science and allegedly 30 other clinic ready compounds that a reasonably competent business person could strike a decent deal to sell this company. McCaffrey told me after the BoM announcement that management figured the company had an EV of $4B. That was before any of the covid potential or the potential in NAFLD was identified. I think most investors would be super happy if he could either cut a deal to sell for $2B or start executing on the business side to bring the market cap up to $2B for a start.

To me a way to get the ball rolling on the market cap front would be to bring in an experienced CEO with a great biotech business track record who has real respect in the biotech financial world. This type of person could probably be attracted by an option package of 5-10 million options exerciseable at todays prices with a negotiated floor price for exercise. Bringing in this person would give RVX a huge boost in credibility and probably immediately increase the share price to at least 80 cents to a dollar if not more. From there it wouldn't be too much of a trick to start doing some meaningful, and dilutively acceptable  financings and get some RVX balls rolling. 

The complete inability of management to execute on anything meaningful gives the whole company the inescapable stench of incompetence and unless some big changes are made I really can't see what moves RVX forward. Hope I am missing something...